{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:27:02Z","timestamp":1779359222808,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.thromres.2020.01.026","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T02:29:04Z","timestamp":1580264944000},"page":"52-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Heparin-induced thrombocytopenia: Diagnostic challenges in intensive care patients especially with extracorporeal circulation"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-4861","authenticated-orcid":false,"given":"Karina","family":"Althaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Hidiatov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Nowak-Harnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Enkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reimer","family":"Riessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-6812","authenticated-orcid":false,"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.026_bb0015","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1016\/j.thromres.2020.01.026_bb0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.thromres.2020.01.026_bb0025","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.thromres.2011.11.041","article-title":"Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring rntithrombotic therapy - an European perspective","volume":"129","author":"Alatri","year":"2012","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0035","first-page":"237","article-title":"Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia","volume":"3","author":"Bakchoul","year":"2012","journal-title":"Ther AdvHematol"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"Warkentin","year":"2003","journal-title":"Br J Haematol"},{"issue":"6 Suppl","key":"10.1016\/j.thromres.2020.01.026_bb0045","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.026_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1538-7836.2011.04552.x","article-title":"Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin-induced thrombocytopenia","volume":"10","author":"Nagler","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"20","key":"10.1016\/j.thromres.2020.01.026_bb0060","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2020.01.026_bb0065","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1182\/bloodadvances.2018018432","article-title":"The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective","volume":"2","author":"George","year":"2018","journal-title":"Blood Adv"},{"issue":"26","key":"10.1016\/j.thromres.2020.01.026_bb0070","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","article-title":"How I evaluate and treat thrombocytopenia in the intensive care unit patient","volume":"128","author":"Greinacher","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.01.026_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/5584_2016_114","article-title":"Deep vein thrombosis in intensive care","volume":"906","author":"Boddi","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2020.01.026_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2019.11.004","article-title":"Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia","volume":"185","author":"Brodard","year":"2019","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2005.09.008","article-title":"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors","volume":"20","author":"Crowther","year":"2005","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/CCM.0000000000002002","article-title":"Overtreatment of heparin-induced thrombocytopenia in the surgical ICU","volume":"45","author":"Harada","year":"2017","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.thromres.2020.01.026_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrc.2009.12.006","article-title":"The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients","volume":"25","author":"Crowther","year":"2010","journal-title":"J Crit Care"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.026_bb0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jcrc.2014.02.004","article-title":"Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial","volume":"29","author":"Crowther","year":"2014","journal-title":"J Crit Care"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.026_bb0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcrc.2013.12.010","article-title":"Assessment of a modified 4T scoring system for heparin-induced thrombocytopenia in critically ill patients","volume":"29","author":"Fiorenza","year":"2014","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.thromres.2020.01.026_bb0115","first-page":"993","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker","year":"2011","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.thromres.2020.01.026_bb0120","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1538-7836.2009.03465.x","article-title":"Prospective evaluation of PF4\/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia","volume":"7","author":"Bakchoul","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11239-014-1105-2","article-title":"Prevalence and clinical implications of anti-PF4\/heparin antibodies in intensive care patients: a prospective observational study","volume":"39","author":"Selleng","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"10.1016\/j.thromres.2020.01.026_bb0130","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/jth.14575","article-title":"Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: review of the literature and alternative anticoagulants","volume":"17","author":"Pollak","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.thromres.2020.01.026_bb0135","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1055\/s-0039-1688827","article-title":"Frequency and clinical impact of platelet factor 4-specific antibodies in patients undergoing extracorporeal membrane oxygenation","volume":"119","author":"Vayne","year":"2019","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.14-1417","article-title":"The role for optical density in heparin-induced thrombocytopenia: a cohort study","volume":"148","author":"Chan","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.026_bb0145","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.13-0057","article-title":"Heparin-induced thrombocytopenia in medical surgical critical illness","volume":"144","author":"Warkentin","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2020.01.026_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22040617","article-title":"Functional assays in the diagnosis of heparin-induced thrombocytopenia: a review","volume":"22","author":"Minet","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.thromres.2020.01.026_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32247-y","article-title":"Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit","volume":"8","author":"Fuchs","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.thromres.2020.01.026_bb0160","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/jth.13497","article-title":"Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibalpha and glycoprotein VI","volume":"14","author":"Lukito","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.thromres.2020.01.026_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5301\/ijao.5000617","article-title":"Changes in the levels of beta-thromboglobulin and inflammatory mediators during extracorporeal membrane oxygenation support","volume":"40","author":"Chung","year":"2017","journal-title":"Int J Artif Organs"},{"issue":"11","key":"10.1016\/j.thromres.2020.01.026_bb0170","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCRESAHA.113.300512","article-title":"Platelets as cellular effectors of inflammation in vascular diseases","volume":"112","author":"Rondina","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2020.01.026_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.thromres.2020.01.026_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.thromres.2019.05.016","article-title":"Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia","volume":"180","author":"Althaus","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.thromres.2020.01.026_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/CCM.0000000000003574","article-title":"Prospective evaluation of a rapid functional assay for heparin-induced thrombocytopenia diagnosis in critically ill patients","volume":"47","author":"Gkalea","year":"2019","journal-title":"Crit Care Med"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820300359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:41:01Z","timestamp":1758735661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820300359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":37,"alternative-id":["S0049384820300359"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.01.026","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-induced thrombocytopenia: Diagnostic challenges in intensive care patients especially with extracorporeal circulation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}